Pediatrix Medical Stock Fair Value – Is Pediatrix Medical Group Inc Undervalued in the Stock Market?

December 22, 2023

🌥️Trending News

Pediatrix Medical ($NYSE:MD) Group Inc is a publicly traded medical practice management company that specializes in neonatal and maternal-fetal care. To examine this, one must consider a variety of factors, such as the company’s industry position, financial metrics, and competitive landscape. An analysis of these factors suggests that the current stock price does not accurately reflect Pediatrix Medical Group Inc’s true value. For instance, the company has seen significant growth in revenue and profits over the past five years, and its financial position is strong. Furthermore, Pediatrix Medical Group Inc enjoys market leadership in its core markets, and its competitive advantages are difficult to replicate.

Additionally, analysts have assigned the company a price-to-earnings ratio that is significantly below the industry average. All of these factors suggest that Pediatrix Medical Group Inc’s stock price is currently undervalued and presents an attractive opportunity for investors.

Price History

On Tuesday, the company’s stock opened at $8.8 and closed at $9.1, up by 4.0% from its last closing price of 8.7. This indicates that the stock is performing well, at least when compared against other stocks in the same sector.

However, it is still important to consider whether the stock is undervalued based on the company’s current financials and future prospects. Analysts will need to look at the company’s fundamentals to determine if this stock is worth investing in at its current value. This includes looking at the company’s financials, such as its earnings history, cash flow, and balance sheet. Analysts should also consider PEDIATRIX MEDICAL‘s growth prospects, competitive landscape, and potential risks that could impact the stock. All of this information can be used to determine if the company is undervalued or not. Investors should do their due diligence before investing in any stock, and this includes researching the company and its fundamentals to make an informed decision. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Pediatrix Medical. More…

    Total Revenues Net Income Net Margin
    2.01k 93.54 5.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Pediatrix Medical. More…

    Operations Investing Financing
    166.76 -46.99 -107.26
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Pediatrix Medical. More…

    Total Assets Total Liabilities Book Value Per Share
    2.33k 1.36k 11.52
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Pediatrix Medical are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    -16.9% -22.3% 8.0%
    FCF Margin ROE ROA
    6.6% 10.5% 4.3%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Pediatrix Medical Stock Fair Value

    As GoodWhale, we have conducted an analysis of PEDIATRIX MEDICAL‘s wellbeing. After careful examination, our proprietary Valuation Line has determined that the fair value of PEDIATRIX MEDICAL share is around $22.2. Unfortunately, the current market value of the stock is only $9.1, which is drastically undervalued by 59.0%. This is a huge opportunity for any investors who are looking to invest in a reliable and profitable company. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The company offers its services to medical groups, hospitals, health plans, and other healthcare organizations. Mednax Inc has a network of over 3,000 physicians and over 200 hospitals. The company has its headquarters in Fort Lauderdale, Florida. Radius Residential Care Ltd is a provider of residential care services in the United Kingdom. The company offers its services to people with learning disabilities, mental health problems, and physical disabilities. Radius Residential Care Ltd has a network of over 100 care homes and employs over 2,000 staff. The company has its headquarters in London, England. Hanger Inc is a provider of orthotic and prosthetic services in the United States. The company offers its services to patients, hospitals, and other healthcare organizations. Hanger Inc has a network of over 700 locations and employs over 4,000 people. The company has its headquarters in Austin, Texas. Ambea AB is a provider of healthcare services in Sweden. The company offers its services to people with mental illness, physical disabilities, and substance abuse problems. Ambea AB has a network of over 60 care homes and employs over 5,000 staff. The company has its headquarters in Stockholm, Sweden.

    – Radius Residential Care Ltd ($NZSE:RAD)

    Radius Residential Care Ltd is a provider of high quality residential aged care services. The company has a market cap of 83.47M as of 2022 and a Return on Equity of 16.16%. Radius Residential Care Ltd operates a network of aged care facilities across Australia and New Zealand. The company is committed to providing quality care for the elderly and to meeting the needs of its residents.

    – Hanger Inc ($LTS:0RNX)

    Amba AB is a Swedish multinational conglomerate with a focus on healthcare and medical technology. The company has a market cap of 4.8 billion as of 2022 and a return on equity of 9.28%. Amba AB’s core businesses include medical devices, diagnostics, and pharmaceuticals. The company has a strong presence in Europe and North America and is expanding into Asia and the rest of the world.

    Summary

    PEDIATRIX Medical Group, Inc. is a provider of physician services and a healthcare provider of neonatal, maternal-fetal and pediatric subspecialty physician services in the United States. Investing in the company stock currently involves analyzing the financial health of the company, its competitive position in the industry, and its potential future growth prospects. From a financial standpoint, PEDIATRIX Medical has been profitable over the last several years and boasts a healthy balance sheet. The company has also enjoyed growth in its revenues, operating income, and net income over the last five years.

    From a competitive position, the company holds strong market share and is well-positioned to take advantage of future growth opportunities in its industry. Finally, there is potential for strong future growth in the healthcare industry as well as within PEDIATRIX Medical’s core markets. Based on all these factors, it appears that PEDIATRIX Medical stock is currently trading at fair value or below it.

    Recent Posts

    Leave a Comment